Abiopharma

News list

Weakley Monica 🟢 acquired 2.4K shares (2 derivative) of AGNT, Inc. (AGNT) at $5.14 Transaction Date: Jul 31, 2026 | Filing ID: 000017

Full text

News bot Aug. 3, 2026, 6:35 p.m.
🔍 Weakley Monica (Executive)

Company: AGNT, Inc. (AGNT)

Report Date: 2026-07-31
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 2,387
Detailed Transactions and Holdings:
- Acquired 558 shares of Common Stock at $5.14 per share (Direct)
  Date: 2026-07-31 | Code: A | equity_swap_involved: false | shares_owned_after: 11,613.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 74 shares of Restricted Stock Units (Derivative)
  Date: 2026-07-31 | Code: A | equity_swap_involved: false | shares_owned_after: 6,376.00 | transaction_form_type: 4 | Footnotes: F2, F3
- Acquired 1,755 shares of Restricted Stock Units (Derivative)
  Date: 2026-07-31 | Code: A | equity_swap_involved: false | shares_owned_after: 8,131.00 | transaction_form_type: 4 | Footnotes: F2, F3
Footnotes:
- F1: These shares were issued to the reporting person under AGNT, Inc.'s (the "Issuer") Agent Equity Program.
- F2: The RSUs are scheduled to vest 100% on June 30, 2029, subject to the reporting person's continued service to the Issuer through the respective vesting date.
- F3: RSUs do not expire; they either vest or are canceled prior to the vesting date.